GSK Plc
NYSE: GSK
$36.29
+$0.39 (+1.1%)
Real Time Data Delayed 15 Min.
GSK Articles
Markets in Europe were up sharply at 6 AM New York time. The FTSE rose 1.6% to 6,306. Barclays (BCS) was up 2.1% to 695. BHP Billiton (BHP) was up 2.6% to 1439. GlaxoSmithKline (GSK) was up 3% to...
Published:
GlaxoSmithKline (GSK) wants everyone, including the FDA, to know that its diabetes drug Avadia is "safe and effective when used appropriately." Almost everyone else thinks that the drug increases...
Published:
Amgen (AMGN) actually rallied a bit after hours yesterday. But, revenue growth was hard to come by. Amgen reported net income of $1.02 billion, or 90 cents per share, for the quarter ended June 30,...
Published:
Sales of GlaxoSmithKline’s (GSK) Avandia products for diabetes dropped 22% because of health concerns about the drug. And the company’s overall reveue missed analyst forecasts. But, the company...
Published:
Imagine that if an aspirin did not get rid of you headache. And, the company that made the pain killer gave you your money back. A new proposal by Johnson & Johnson (JNJ) is for the company to...
Published:
As you will see, the short interest changes in medical and drug stocks of the active NYSE-listed names was a bit of a mixed bag. GlaxoSmithkline (GSK) saw the lagest increase, but its short...
Published:
GlaxoSmithKline (GSK-NYSE) has been under significant pressure of late because of the New England Journal of Medicine showing greatly increased risks of a heart attack for diabetes patients that have...
Published:
Stock Tickers: MRK, PFE, JNJ, GSK, SGP, LLY, WYE, NVS, NVO On tonight’s MAD MONEY on CNBC, Jim Cramer said he keeps getting asked about Big Pharma drug stocks. He’d rather focus on farms, but...
Published:
(AAUK) Anglo American’s CEO will become a non-executive member of the board of directors at BP (BP).(ACAD) Acadia Pharmaceuticals traded up over 10% after Jim Cramer touted the stock as a...
Published:
This weekend we have the mother of all future cancer treatment conferences: ASCO, or The American Society of Clinical Oncology. Cancer stocks in the last few weeks have been seeing a muted response...
Published:
Some sectors showed mixed results in the short selling, but the Big Pharma and medical instruments and related companies saw an increased activity in short selling in May versus April. Below is the...
Published: